MRC1 and neoplasm: Variant-Class 4 includes IVS+-1 or IVS+-2 mutations resulting in splicing aberrations, variants abrogating mRNA/protein function based on laboratory assays, evidence of cosegregation with disease or MSI tumor, and/or loss of MMR protein expression.